Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics of OPRM1
Richard C. Crist, Wade H. Berrettini
Pharmacology Biochemistry and Behavior (2013) Vol. 123, pp. 25-33
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Opioid receptors: drivers to addiction?
Emmanuel Darcq, Brigitte L. Kieffer
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 499-514
Closed Access | Times Cited: 304
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
Tae‐Hwi Schwantes‐An, Juan Zhang, Li‐Shiun Chen, et al.
Behavior Genetics (2015) Vol. 46, Iss. 2, pp. 151-169
Open Access | Times Cited: 114
Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease
Julia Kraemmer, Kara Smith, Daniel Weintraub, et al.
Journal of Neurology Neurosurgery & Psychiatry (2016) Vol. 87, Iss. 10, pp. 1106-1111
Open Access | Times Cited: 108
The Impact of Genetic Variation on Sensitivity to Opioid Analgesics in Patients with Postoperative Pain: A Systematic Review and Meta-Analysis
Prof. Lin Lu
Pain Physician (2015) Vol. 2;18, Iss. 2;3, pp. 131-152
Open Access | Times Cited: 104
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1
Andrew H. Smith, Kevin P. Jensen, Jason Li, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 3, pp. 346-352
Open Access | Times Cited: 90
Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction
Rachel L. Kember, Rachel Vickers‐Smith, Heng Xu, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 10, pp. 1279-1287
Open Access | Times Cited: 67
The Association Between Genetic Factors and Temporomandibular Disorders: A Systematic Literature Review
Ahid Amer Alshahrani, Ravinder S Saini, Abdulmajeed Okshah, et al.
Archives of Oral Biology (2024) Vol. 166, pp. 106032-106032
Open Access | Times Cited: 8
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
Jamie Burns, Danielle S. Kroll, Dana E. Feldman, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 70
The ACTTION–APS–AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions
Michael L. Kent, Patrick J. Tighe, Inna Belfer, et al.
Journal of Pain (2017) Vol. 18, Iss. 5, pp. 479-489
Open Access | Times Cited: 65
Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Zhi-Wei Zhou, Xiao-Wu Chen, Kevin Sneed, et al.
Drugs (2015) Vol. 75, Iss. 6, pp. 589-631
Closed Access | Times Cited: 64
The Skin–Brain Axis: From UV and Pigmentation to Behaviour Modulation
Anna A. Ascsillán, Lajos V. Kemény
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6199-6199
Open Access | Times Cited: 6
The ACTTION–APS–AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions
Michael Kent, Patrick J. Tighe, Inna Belfer, et al.
Pain Medicine (2017) Vol. 18, Iss. 5, pp. 947-958
Open Access | Times Cited: 58
Pain management of the cancer patient
Stephan A. Schug, Chandani Chandrasena
Expert Opinion on Pharmacotherapy (2014) Vol. 16, Iss. 1, pp. 5-15
Closed Access | Times Cited: 57
Genetic Testing for Opioid Pain Management: A Primer
Deepti Agarwal, Mercy A. Udoji, Andrea M. Trescot
Pain and Therapy (2017) Vol. 6, Iss. 1, pp. 93-105
Open Access | Times Cited: 50
Fatigue in breast cancer patients on chemotherapy: a cross-sectional study exploring clinical, biological, and genetic factors
Aline Hajj, Rami Chamoun, Pascale Salameh, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Transcriptome Analysis of Trigeminal Ganglion and Medullary Dorsal Horn in Mice to Identify Potential Targets for Pulpitis-Induced Pain
Zhuo Yu, Xiaoning Kang, Jialin Si, et al.
ACS Omega (2025)
Open Access
The pain interactome: Connecting pain-specific protein interactions
Daniel Jamieson, Andrew Moss, Michael A. Kennedy, et al.
Pain (2014) Vol. 155, Iss. 11, pp. 2243-2252
Open Access | Times Cited: 42
<p><em>OPRM1</em> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches</p>
Malik Mumtaz Taqi, Muhammad Faisal, Hadar Zaman
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 361-368
Open Access | Times Cited: 39
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease
Florence Cormier‐Dequaire, Samir Bekadar, Mathieu Anheim, et al.
Movement Disorders (2018) Vol. 33, Iss. 12, pp. 1878-1886
Closed Access | Times Cited: 38
Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1, the mu‐opioid receptor gene, on response to naltrexone treatment of alcohol use disorder
Emily E. Hartwell, Richard Feinn, Paige E. Morris, et al.
Addiction (2020) Vol. 115, Iss. 8, pp. 1426-1437
Open Access | Times Cited: 33
The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review
Isabelle E. Bauer, Jair C. Soares, David A. Nielsen
American Journal on Addictions (2015) Vol. 24, Iss. 1, pp. 15-23
Closed Access | Times Cited: 40
Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches
Maite Solas, Fermı́n I. Milagro, Diego Martínez‐Urbistondo, et al.
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 7, pp. 575-593
Closed Access | Times Cited: 36
Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms
Gualberto Ruaño
Pain Physician (2018) Vol. 1, Iss. 21;1, pp. E611-E621
Open Access | Times Cited: 30
Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism
Caroline A. Browne, Rebecca L. Erickson, Julie A. Blendy, et al.
Neuropharmacology (2017) Vol. 117, pp. 401-407
Open Access | Times Cited: 28
Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction
Danni Cao, Jingjing Shi, Wei Hao, et al.
European Journal of Pharmacology (2016) Vol. 780, pp. 129-135
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top